Uk Mhra Gmp
ROSEMONT PHARMACEUTICALS LIMITEDROSEMONT PHARMACEUTICALS LIMITED – UK MHRA GMP Certificate UK MIA 427 Insp GMP/IMP 427/15276-0022[H]
Record Details
This Uk Mhra Gmp record concerns ROSEMONT PHARMACEUTICALS LIMITED, with an inspection on February 19, 2026, issued by the MHRA, covering drugs.
- Compliance status
- GMPC
- Certificate type
- GMP/IMP
- Inspection date
- February 19, 2026
- Issued
- February 27, 2026
- MIA number
- UK MIA 427
- Site address
- ROSEMONT HOUSE, YORKDALE INDUSTRIAL PARK, BRAITHWAITE STREET, LEEDS, LS11 9XE, UNITED KINGDOM
- Country
- UNITED KINGDOM
- Products
- Human Medicinal Products
- Manufacturing operations
- 1. MANUFACTURING OPERATIONS [ 1.2 ] Non-sterile products [ 1.2.1 ] Non-Sterile Products (processing operations for the following dosage forms) [ 1.2.1.6 ] Liquids for internal use [ 1.2.1.8 ] Other solid dosage forms [ 1.2.1.17 ] Other non-sterile medicinal productsManufacture of cytotoxic agents - Methotrexate disodium [ 1.2.2 ] Batch certification [ 1.5 ] Packaging [ 1.5.1 ] Primary packaging [ 1.5.1.6 ] Liquids for internal use [ 1.5.2 ] Secondary packaging [ 1.6 ] Quality control testing [ 1.6.2 ] Microbiological: non-sterility [ 1.6.3 ] Chemical/Physical
- Restrictions
- This certificate is issued based on a desk-based assessment of GMP compliance information provided by the manufacturer. This certificate should be used in combination with the relevant authorisation/registration. A risk-based site inspection programme remains in force. The MIA(IMP) certificate is granted for secondary packaging operations limited to open labels only with no randomisation or blinding.
View Company Profile
ID · 392d6b78-bf9e-45d4-8a63-0643f6e6749a
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.